Charles J. Homcy

Insider Reports History

Entity
Individual
Location
Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco, CA
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles J. Homcy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. Director Common Stock 1.23M $45.8M $37.21 Feb 16, 2024 Direct
BridgeBio Pharma, Inc. Director Restricted Stock Units 0 $0 $37.21 Feb 16, 2024 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 26K Jun 21, 2024 Direct
PLIANT THERAPEUTICS, INC. Director Stock Option (right to buy) 13.3K Jun 29, 2021 Direct

Insider Reports Filed by Charles J. Homcy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBIO BridgeBio Pharma, Inc. Jun 21, 2024 1 $0 4 Jun 25, 2024 Director
BBIO BridgeBio Pharma, Inc. Feb 16, 2024 3 -$56.1K 4 Feb 21, 2024 Director
BBIO BridgeBio Pharma, Inc. Nov 16, 2023 3 -$37.5K 4 Nov 20, 2023 Director
BBIO BridgeBio Pharma, Inc. Aug 16, 2023 3 -$38.8K 4 Aug 18, 2023 Director
BBIO BridgeBio Pharma, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
BBIO BridgeBio Pharma, Inc. May 16, 2023 3 -$18.3K 4 May 18, 2023 Director
BBIO BridgeBio Pharma, Inc. Feb 16, 2023 3 -$19.4K 4 Feb 21, 2023 Director
BBIO BridgeBio Pharma, Inc. Nov 16, 2022 3 -$12.5K 4 Nov 18, 2022 Director
BBIO BridgeBio Pharma, Inc. Aug 16, 2022 3 -$14.3K 4 Aug 18, 2022 Director
BBIO BridgeBio Pharma, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
BBIO BridgeBio Pharma, Inc. May 16, 2022 3 -$10.4K 4 May 18, 2022 Director
BBIO BridgeBio Pharma, Inc. Feb 28, 2022 1 $0 4 Mar 15, 2022 Director
BBIO BridgeBio Pharma, Inc. Dec 2, 2021 1 $0 4 Dec 6, 2021 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director
BBIO BridgeBio Pharma, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director